RAD001 Phase II Trial Results Positive In Patients With Advanced Gastric Cancer After Failure Of One Or More Prior ... (Medical News Today) PDF Print

Data released show RAD001 (also known as everolimus; proposed brand name Afinitor(R)) halted tumor growth in 55% of patients with advanced gastric cancer, a condition for which there are limited treatment options. In addition, 45% of patients in the study demonstrated some tumor shrinkage(1).

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.